FDA Warns Against Compounded Versions Of Semaglutide For Diabetes, Weight Loss
Recently, the US Food and Drug Administration has issued warning Tuesday against a compounded versions of the drug semaglutide, which is approved for treatment of diabetes and excess weight.
Reminding that Compounding “is…